SM
TRAW icon

Sabby Management’s Traws Pharma TRAW Stock Holding History

Sabby Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,310
Closed -$3.35M – 107
2019
Q4 		$3.35M Buy
23,310
+21,169
+989% +$3.96M 0.93% 12
2019
Q3 		$682K Buy
+2,141
New +$1.84M 0.37% 29
2019
Q1 		– Sell
-127
Closed -$101K – 130
2018
Q4 		$101K Buy
+127
New +$216K 0.02% 82
2018
Q3 		– Sell
-11
Closed -$26K – 149
2018
Q2 		$26K Sell
11
-60
-85% -$174K ﹤0.01% 128
2018
Q1 		$334K Sell
71
-29
-29% -$207K 0.04% 111
2017
Q4 		$842K Sell
100
-50
-33% -$515K 0.08% 83
2017
Q3 		$1.44M Buy
150
+11
+8% +$114K 0.09% 65
2017
Q2 		$1.69M Buy
139
+71
+104% +$882K 0.11% 79
2017
Q1 		$1.17M Sell
68
-12
-15% -$186K 0.06% 124
2016
Q4 		$1.03M Buy
80
+10
+14% +$148K 0.06% 143
2016
Q3 		$1.04M Buy
+70
New +$1.43M 0.04% 184

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's TRAW Position: Q1 2020 in Review

Sabby Management sold out of Traws Pharma (TRAW) in Q1 2020, closing a stake of 23,310 shares — an estimated $3.35M sold.

Sabby Management first reported a position in TRAW in Q3 2016 and held it in 11 quarters. The position peaked at $3.35M in Q4 2019. 21 funds tracked by Wall St. Rank hold TRAW as of Q1 2020.

  • Sabby Management reported no remaining Traws Pharma position as of Q1 2020 after selling out during the quarter.
  • Sabby Management sold 23,310 Traws Pharma shares in Q1 2020, an estimated $3.35M.
  • Sabby Management first reported a position in Traws Pharma in Q3 2016 and held it in 11 quarters.
  • Sabby Management's Traws Pharma position peaked at $3.35M in Q4 2019.
  • 21 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2020.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.